Psychiatry Research: Neuroimaging
Volume 155, Issue 2 , Pages 147-154 , 15 July 2007

Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease

  • Aoife Hunt

      Affiliations

    • Section for Geriatric Psychiatry, Ruprecht-Karls-University Heidelberg, Voss-Str.4, D-69115 Heidelberg, Germany
    • ,
  • Peter Schönknecht

      Affiliations

    • Section for Geriatric Psychiatry, Ruprecht-Karls-University Heidelberg, Voss-Str.4, D-69115 Heidelberg, Germany
    • ,
  • Marcus Henze

      Affiliations

    • German Cancer Research Center Heidelberg and Department of Nuclear Medicine, Ruprecht-Karls-University Heidelberg, Germany
    • ,
  • Ulrich Seidl

      Affiliations

    • Section for Geriatric Psychiatry, Ruprecht-Karls-University Heidelberg, Voss-Str.4, D-69115 Heidelberg, Germany
    • ,
  • Uwe Haberkorn

      Affiliations

    • German Cancer Research Center Heidelberg and Department of Nuclear Medicine, Ruprecht-Karls-University Heidelberg, Germany
    • ,
  • Johannes Schröder

      Affiliations

    • Section for Geriatric Psychiatry, Ruprecht-Karls-University Heidelberg, Voss-Str.4, D-69115 Heidelberg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 6221 564403; fax: +49 6221 565327.

Received 17 August 2004 ,Revised 10 April 2006 ,Accepted 7 December 2006.

References 

  1. Arnaiz E, Jelic V, Almkist O, Wahlund L-O, Winblad B, Valind S, et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. NeuroReport. 2001;12:851–855
  2. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica. 1991;82:239–259
  3. Buchsbaum M, Kesslak JP, Lynch G, Chui H, Wu J, Sicott N, et al. Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls. Preliminary studies. Archives of General Psychiatry. 1991;48:840–847
  4. Chételat G, Desgranges B, de la Sayette MD, Viader MD, Eustache F, Baron J-C. Mild cognitive impairment. Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?. Neurology. 2003;60:1374–1377
  5. De Leon MJ, Convit A, Wolf OT, Tarshish CY, DeSanti S, Rusinek H, et al. Prediction of cognitive decline in normal elderly subjects with 2-(18F)-fluoro-2-deoxy-d-glucose/positron-emission-tomography (FDG/PET). Proceedings of the National Academy of Sciences of the United States of America. 2001;98:10966–10971
  6. De Santi S, de Leon M, Rusinek H, Convit A, Tarshish A, Tsui WH, et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiology of Aging. 2001;22:529–539
  7. Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. European Journal of Nuclear Medicine and Molecular Imaging. 2003;30:1104–1113
  8. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB. The preclinical phase of Alzheimer disease. A 22-year prospective study of the Framingham cohort. Archives of Neurology. 2000;57:808–813
  9. Encinas M, De Juan R, Marcos A, Gil P, Barabash A, Fernandez C, et al. Regional blood flow assessed with 99mTc_ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 2003;30:1473–1480
  10. Folstein MF, Folstein SE, MsHugh PR. ‘Mini mental state’. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;12:189–198
  11. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping. 1995;2:189–210
  12. Hachinski VL, Iliff D, Zihka E, Du Boulay GH, McAllister VL, Marshall J, et al. Cerebral blood flow in dementia. Archives of Neurology. 1975;32:632–637
  13. Haxby JV, Duara R, Grady CL, Cutler NR, Rapoport SI. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism. 1985;5:193–200
  14. Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frölich L, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. NeuroImage. 2002;17:302–316
  15. Hsiung GY, Sadovnick AD, Feldman H. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. CMAJ. 2004;171:863–867
  16. Huang C, Wahlund LO, Svensson L, Winblad B, Julin P. Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment. BMC (Biomedcentral) Neurology. 2002;2:9
  17. Ishiwata A, Kitamura S, Nagazumi A, Terashi A. Cerebral blood flow of patients with age-associated memory impairment and the early stage of Alzheimer's disease. A study by SPECT using the ARG method. Nippon Ika Daigaku Zasshi. 1998;65:140–147
  18. Johnson KA, Jones K, Holman BL, Becker JA, Spiers PA, Satlin A, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology. 1998;50:1563–1571
  19. Levy R. Aging-associated cognitive decline. International Psychogeriatrics. 1994;6:63–68
  20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939–965
  21. Morris JC. The Clinical Dementia Rating. Current version and scoring rules. Neurology. 1993;43:2412–2414
  22. Nestor PJ, Fryer TD, Ikeda M, Hodges JR. Retrosplenial cortex (BA 29/30) hypometabolism in mild cognitive impairment (prodromal Alzheimer's disease). European Journal of Neuroscience. 2003;18:2663–2667
  23. Nestor PJ, Scheltens P, Hodges JR. Advances in the early detection of Alzheimer's disease. Nature Medicine. 2004;10:S34–S41
  24. Okamura N, Shinkawa M, Arai H, Matsui T, Nakajo K, Maruyama M, et al. Prediction of progression in patients with mild cognitive impairment using IMP-SPECT. Nippon Ronen Igakkai Zasshi. 2000;37:974–978
  25. Pantel J, Schönknecht P, Essig M, Amann M, Eysenbach K, Schad LR, et al. Progressive medial temporal lobe changes in Alzheimer's disease revealed by quantitative MRI: potential use for monitoring of drug-related changes. Drug Development Research. 2002;56:51–56
  26. Pantel J, Kratz B, Essig M, Schröder J. Parahippocampal volume deficits in subjects with aging-associated cognitive decline. American Journal of Psychiatry. 2003;160:379–382
  27. Pantel J, Schönknecht P, Essig M, Schröder J. Distribution of cerebral atrophy as assessed by magnetic resonance imaging reflects patterns of neuropsychological deficits in Alzheimer's dementia. Neuroscience Letters. 2004;361:17–20
  28. Petersen PC, Morris JC. In:  Petersen PC editors. Clinical Features (of MCI) in Mild Cognitive Impairment, Aging to Alzheimer's Disease. New York: University Press; 2003;
  29. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, et al. Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors. Dementia and Geriatric Cognitive Disorders. 2006;21:51–58
  30. Ritchie K, Arteron S, Touchon J. Classification criteria for mild cognitive impairment — a population-based validation study. Neurology. 2001;56:37–42
  31. Scarmeas N, Stern Y. Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Current Neurology and Neuroscience Reports. 2004;4:374–380
  32. Schönknecht P, Pantel J, Hartmann T, Werle E, Volkmann M, Essig M, et al. Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy. Psychiatry Research: Neuroimaging. 2003;120:231–238
  33. Schönknecht P, Pantel J, Kruse A, Schröder J. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young–old subjects. American Journal of Psychiatry. 2005;162:2071–2077
  34. Schröder J, Kratz B, Pantel J, Minnemann E, Lehr U, Sauer H. Prevalence of mild cognitive impairment in a community sample. Journal of Neural Transmission Supplement. 1998;54:51–59
  35. Schröder J, Buchsbaum MS, Shihabuddin L, Tang C, Wei T, Spiegel-Cohen J, et al. Patterns of cortical activity and memory performance in Alzheimer's disease. Biological Psychiatry. 2001;49:426–436
  36. Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. Journal of the American Medical Association. 2001;286:2110–2117
  37. Staffen W, Schonauer U, Zauner H, Spindler I, Mair A, Iglseder B, et al. Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation. Journal of Neural Transmission. 2005;286:2110–2117
  38. Talairach JA, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. Paris: Thieme; 1988;
  39. Tanaka M, Fukuyama H, Yamauchi H, Narita M, Nabatame H, Yokode M, et al. Regional cerebral blood flow abnormalities in nondemented patients with memory impairment. Journal of Neuroimaging. 2002;12:112–118
  40. Winblad W, Palmer K, Kivipelto M, Jelic V, Fratiglioni L. Mild cognitive impairment — beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine. 2004;256:240–246

PII: S0925-4927(06)00228-9

doi: 10.1016/j.pscychresns.2006.12.003

Psychiatry Research: Neuroimaging
Volume 155, Issue 2 , Pages 147-154 , 15 July 2007

Article Tools

* Image Usage & Resolution